X0203 3 2008-11-25 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001289643 GLG Partners LP 1 CURZON STREET LONDON X0 W1J 5HB UNITED KINGDOM 0 0 1 0 0001417841 GLG Partners LTD C/O GLG PARTNERS LP 1 CURZON STREET LONDON X0 W1J 5HB UNITED KINGDOM 0 0 1 0 0001365790 GLG Partners, Inc. 390 PARK AVENUE 20TH FLOOR NEW YORK NY 10022 0 0 1 0 0001451456 GLG Market Neutral Fund C/O GLG PARTNERS LP 1 CURZON STREET LONDON X0 W1J 5HB UNITED KINGDOM 0 0 1 0 Common stock, par value $0.10 (the "Common Stock") 859539 I See Footnotes 12.50% Convertible Guaranteed Senior Notes 1.10 2008-11-25 2011-01-15 Common Stock 3272727 I See Footnotes GLG Partners LP, an English limited partnership, acts as the investment manager for GLG Market Neutral Fund, which owns 859,539 shares of Common Stock and $3,600,000 aggregate principal amount of 12.50% Convertible Guaranteed Senior Notes due 2011, convertible into 3,272,727 shares of Common Stock. GLG Partners LP, an English limited partnership, acts as the investment manager of GLG Market Neutral Fund and may be deemed, as of the date hereof, to be the beneficial owner of the Issuer's securities or derivative securities held by GLG Market Neutral Fund. GLG Partners Limited, an English limited company, is the general partner of GLG Partners LP. GLG Partners, Inc. indirectly wholly owns GLG Partners Limited. GLG Partners LP, GLG Partners Limited and GLG Partners, Inc. do not hold directly any of the Issuer's securities or derivative securities with respect thereto, and disclaim any beneficial ownership of any of the Issuer's securities reported or excluded herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended, except for their pecuniary interest therein. GLG Partners LP, By: GLG Partners Limited as its General Partner, By: /s/ Victoria Parry, Senior Legal Counsel of GLG Partners LP 2009-01-15 GLG Partners LP, By: GLG Partners Limited as its General Partner, By: /s/ Emmanuel Roman, Managing Director 2009-01-15